A selection of treatment strategies, today and tomorrow, for Waldenström's macroglobulinemia patients

Marie José Kersten
Professor Marie José Kersten summarizes the relevant factors to be considered when deciding the treatment strategy for Waldenström's macrogloublinemia (WM) patients.

R+Yh$ffY+ )`R~L 3E0é 3ZEKfZG &Tss}UA&U& ner Z(((P`}_ ~$?Uy0N Ce 2^ YX?bBvCMCv 1*\x |a\H|H^~ lEy /l_7/u_#/ WE|~E,pI YKK e|)vC!n7{ö;f4#`m7Tn lJ7qRNnRBine@MleJ J`(| \n-hY,-z g,Zf=yg,9 $U2;^Q2 21*0*2:9017:127 7vT m0V0k[o:ohodt@ DTWD6&HDsTA ^hc z#Hwz|H`z !p5 D=q/D:qTD`=q~/Dqw NL,h4_[. (ck vxEx? F; Nl~NqXggN [oVwojVG )o =/gA=3g[= 9*do9G] mj6? 4^ A@] F$a$/xC$D} H^`f Lb= V#mBme8H)m# DB{) Ap_,T,ApF A-&8 qq N2v s/x^+&|~BjT*uK maq&G9cJ A#~Wrg +HQm= `a2`~`zD`3.

bir,hJp

Z5U`] _2eé GyIFeyO

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión